nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—multiple sclerosis—amyotrophic lateral sclerosis	0.711	1	CtDrD
Betamethasone—PTGS2—amyotrophic lateral sclerosis	0.172	1	CbGaD
Betamethasone—Personality change—Riluzole—amyotrophic lateral sclerosis	0.00501	0.0746	CcSEcCtD
Betamethasone—Panophthalmitis—Riluzole—amyotrophic lateral sclerosis	0.00393	0.0586	CcSEcCtD
Betamethasone—Osteonecrosis—Riluzole—amyotrophic lateral sclerosis	0.00258	0.0384	CcSEcCtD
Betamethasone—Endophthalmitis—Riluzole—amyotrophic lateral sclerosis	0.00202	0.0301	CcSEcCtD
Betamethasone—Osteoporosis—Riluzole—amyotrophic lateral sclerosis	0.00171	0.0255	CcSEcCtD
Betamethasone—Blepharitis—Riluzole—amyotrophic lateral sclerosis	0.00156	0.0233	CcSEcCtD
Betamethasone—Embolism—Riluzole—amyotrophic lateral sclerosis	0.0015	0.0223	CcSEcCtD
Betamethasone—Delusion—Riluzole—amyotrophic lateral sclerosis	0.00136	0.0202	CcSEcCtD
Betamethasone—Mania—Riluzole—amyotrophic lateral sclerosis	0.00132	0.0197	CcSEcCtD
Betamethasone—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.00129	0.0192	CcSEcCtD
Betamethasone—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.00128	0.019	CcSEcCtD
Betamethasone—Abscess—Riluzole—amyotrophic lateral sclerosis	0.00121	0.0181	CcSEcCtD
Betamethasone—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.00119	0.0177	CcSEcCtD
Betamethasone—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.00117	0.0174	CcSEcCtD
Betamethasone—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00109	0.0163	CcSEcCtD
Betamethasone—PTGS2—hindlimb—amyotrophic lateral sclerosis	0.00108	0.0697	CbGeAlD
Betamethasone—NR3C2—hindbrain—amyotrophic lateral sclerosis	0.00106	0.0684	CbGeAlD
Betamethasone—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00106	0.0157	CcSEcCtD
Betamethasone—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00102	0.0152	CcSEcCtD
Betamethasone—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.00102	0.0151	CcSEcCtD
Betamethasone—Cataract—Riluzole—amyotrophic lateral sclerosis	0.00101	0.015	CcSEcCtD
Betamethasone—PGR—hindbrain—amyotrophic lateral sclerosis	0.000989	0.0636	CbGeAlD
Betamethasone—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.000961	0.0143	CcSEcCtD
Betamethasone—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.000949	0.0141	CcSEcCtD
Betamethasone—PTGS2—appendage—amyotrophic lateral sclerosis	0.00093	0.0598	CbGeAlD
Betamethasone—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.000912	0.0136	CcSEcCtD
Betamethasone—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.000868	0.0129	CcSEcCtD
Betamethasone—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.000855	0.0127	CcSEcCtD
Betamethasone—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.000825	0.0123	CcSEcCtD
Betamethasone—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.000802	0.0119	CcSEcCtD
Betamethasone—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.000769	0.0115	CcSEcCtD
Betamethasone—NR3C1—nerve—amyotrophic lateral sclerosis	0.000762	0.049	CbGeAlD
Betamethasone—Injury—Riluzole—amyotrophic lateral sclerosis	0.000759	0.0113	CcSEcCtD
Betamethasone—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.000742	0.0111	CcSEcCtD
Betamethasone—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00072	0.0107	CcSEcCtD
Betamethasone—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.000714	0.0106	CcSEcCtD
Betamethasone—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.000697	0.0104	CcSEcCtD
Betamethasone—Migraine—Riluzole—amyotrophic lateral sclerosis	0.000686	0.0102	CcSEcCtD
Betamethasone—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.000686	0.0102	CcSEcCtD
Betamethasone—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.000681	0.0101	CcSEcCtD
Betamethasone—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.000663	0.00988	CcSEcCtD
Betamethasone—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.000661	0.00984	CcSEcCtD
Betamethasone—PLA2G1B—nervous system—amyotrophic lateral sclerosis	0.000645	0.0415	CbGeAlD
Betamethasone—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.000635	0.00945	CcSEcCtD
Betamethasone—PLA2G1B—central nervous system—amyotrophic lateral sclerosis	0.000621	0.0399	CbGeAlD
Betamethasone—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.000615	0.00916	CcSEcCtD
Betamethasone—NR3C2—brainstem—amyotrophic lateral sclerosis	0.00061	0.0392	CbGeAlD
Betamethasone—PGR—Nuclear Receptor transcription pathway—RARA—amyotrophic lateral sclerosis	0.000607	0.0186	CbGpPWpGaD
Betamethasone—PGR—Nuclear signaling by ERBB4—GFAP—amyotrophic lateral sclerosis	0.000601	0.0184	CbGpPWpGaD
Betamethasone—Fluocinolone Acetonide—PLA2G4A—amyotrophic lateral sclerosis	0.000575	0.521	CrCbGaD
Betamethasone—NR3C1—hindbrain—amyotrophic lateral sclerosis	0.000571	0.0367	CbGeAlD
Betamethasone—PLA2G1B—Glycerophospholipid biosynthesis—CHAT—amyotrophic lateral sclerosis	0.000557	0.017	CbGpPWpGaD
Betamethasone—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.000548	0.00817	CcSEcCtD
Betamethasone—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.000545	0.00812	CcSEcCtD
Betamethasone—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00053	0.00789	CcSEcCtD
Betamethasone—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.000527	0.00785	CcSEcCtD
Betamethasone—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.000527	0.00785	CcSEcCtD
Betamethasone—PLA2G1B—Phospholipid metabolism—PLB1—amyotrophic lateral sclerosis	0.000513	0.0157	CbGpPWpGaD
Betamethasone—PLA2G1B—brain—amyotrophic lateral sclerosis	0.000493	0.0317	CbGeAlD
Betamethasone—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.000491	0.00732	CcSEcCtD
Betamethasone—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.000485	0.00722	CcSEcCtD
Betamethasone—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000482	0.00719	CcSEcCtD
Betamethasone—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00048	0.00715	CcSEcCtD
Betamethasone—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.000451	0.00672	CcSEcCtD
Betamethasone—NR3C1—Nuclear Receptors—RARA—amyotrophic lateral sclerosis	0.000444	0.0136	CbGpPWpGaD
Betamethasone—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.000438	0.00652	CcSEcCtD
Betamethasone—NR3C2—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.000432	0.0132	CbGpPWpGaD
Betamethasone—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.000431	0.00642	CcSEcCtD
Betamethasone—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000426	0.00635	CcSEcCtD
Betamethasone—NR3C2—medulla oblongata—amyotrophic lateral sclerosis	0.000425	0.0273	CbGeAlD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—GRN—amyotrophic lateral sclerosis	0.000419	0.0128	CbGpPWpGaD
Betamethasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—ATF1—amyotrophic lateral sclerosis	0.000394	0.012	CbGpPWpGaD
Betamethasone—Fluticasone Propionate—PLA2G4A—amyotrophic lateral sclerosis	0.000393	0.356	CrCbGaD
Betamethasone—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00039	0.0058	CcSEcCtD
Betamethasone—PLA2G1B—Phospholipid metabolism—CHAT—amyotrophic lateral sclerosis	0.000388	0.0119	CbGpPWpGaD
Betamethasone—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.000384	0.00572	CcSEcCtD
Betamethasone—NR3C2—spinal cord—amyotrophic lateral sclerosis	0.000379	0.0244	CbGeAlD
Betamethasone—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000379	0.00564	CcSEcCtD
Betamethasone—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000377	0.00562	CcSEcCtD
Betamethasone—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000377	0.00561	CcSEcCtD
Betamethasone—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000369	0.0055	CcSEcCtD
Betamethasone—PLA2G1B—Fc-epsilon receptor I signaling in mast cells—PLA2G4A—amyotrophic lateral sclerosis	0.000369	0.0113	CbGpPWpGaD
Betamethasone—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000364	0.00542	CcSEcCtD
Betamethasone—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000363	0.0054	CcSEcCtD
Betamethasone—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000357	0.00533	CcSEcCtD
Betamethasone—NR3C1—embryo—amyotrophic lateral sclerosis	0.000357	0.023	CbGeAlD
Betamethasone—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000356	0.00531	CcSEcCtD
Betamethasone—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000353	0.00526	CcSEcCtD
Betamethasone—NR3C1—Nuclear Receptor transcription pathway—RARA—amyotrophic lateral sclerosis	0.000351	0.0107	CbGpPWpGaD
Betamethasone—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.000343	0.00511	CcSEcCtD
Betamethasone—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000343	0.00511	CcSEcCtD
Betamethasone—PTGS2—Spinal Cord Injury—PTPRZ1—amyotrophic lateral sclerosis	0.000341	0.0104	CbGpPWpGaD
Betamethasone—Infection—Riluzole—amyotrophic lateral sclerosis	0.00034	0.00507	CcSEcCtD
Betamethasone—Shock—Riluzole—amyotrophic lateral sclerosis	0.000337	0.00502	CcSEcCtD
Betamethasone—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000336	0.00501	CcSEcCtD
Betamethasone—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000336	0.005	CcSEcCtD
Betamethasone—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000334	0.00498	CcSEcCtD
Betamethasone—PTGS2—Signaling mediated by p38-alpha and p38-beta—RAB5A—amyotrophic lateral sclerosis	0.000334	0.0102	CbGpPWpGaD
Betamethasone—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000331	0.00494	CcSEcCtD
Betamethasone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—TPK1—amyotrophic lateral sclerosis	0.00033	0.0101	CbGpPWpGaD
Betamethasone—NR3C2—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.000328	0.01	CbGpPWpGaD
Betamethasone—NR3C1—brainstem—amyotrophic lateral sclerosis	0.000327	0.021	CbGeAlD
Betamethasone—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000327	0.00487	CcSEcCtD
Betamethasone—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00032	0.00477	CcSEcCtD
Betamethasone—NR3C2—nervous system—amyotrophic lateral sclerosis	0.000319	0.0205	CbGeAlD
Betamethasone—PGR—Nuclear signaling by ERBB4—ERBB4—amyotrophic lateral sclerosis	0.000312	0.00956	CbGpPWpGaD
Betamethasone—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000312	0.00465	CcSEcCtD
Betamethasone—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00031	0.00462	CcSEcCtD
Betamethasone—PTGS2—embryo—amyotrophic lateral sclerosis	0.000309	0.0199	CbGeAlD
Betamethasone—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000308	0.00458	CcSEcCtD
Betamethasone—NR3C2—central nervous system—amyotrophic lateral sclerosis	0.000308	0.0198	CbGeAlD
Betamethasone—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000302	0.00449	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000301	0.00921	CbGpPWpGaD
Betamethasone—NR3C2—cerebellum—amyotrophic lateral sclerosis	0.000301	0.0193	CbGeAlD
Betamethasone—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000298	0.00444	CcSEcCtD
Betamethasone—PGR—nervous system—amyotrophic lateral sclerosis	0.000297	0.0191	CbGeAlD
Betamethasone—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000296	0.00441	CcSEcCtD
Betamethasone—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000295	0.0044	CcSEcCtD
Betamethasone—Pain—Riluzole—amyotrophic lateral sclerosis	0.000293	0.00437	CcSEcCtD
Betamethasone—PGR—central nervous system—amyotrophic lateral sclerosis	0.000286	0.0184	CbGeAlD
Betamethasone—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000282	0.00421	CcSEcCtD
Betamethasone—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00028	0.00418	CcSEcCtD
Betamethasone—PGR—cerebellum—amyotrophic lateral sclerosis	0.000279	0.018	CbGeAlD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000275	0.00843	CbGpPWpGaD
Betamethasone—PLA2G1B—Glycerophospholipid biosynthesis—PLA2G4A—amyotrophic lateral sclerosis	0.000275	0.00841	CbGpPWpGaD
Betamethasone—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000272	0.00406	CcSEcCtD
Betamethasone—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000271	0.00404	CcSEcCtD
Betamethasone—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000271	0.00404	CcSEcCtD
Betamethasone—CYP19A1—FSH signaling pathway—BDNF—amyotrophic lateral sclerosis	0.000271	0.00828	CbGpPWpGaD
Betamethasone—CYP19A1—nervous system—amyotrophic lateral sclerosis	0.000267	0.0172	CbGeAlD
Betamethasone—PGR—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.000263	0.00806	CbGpPWpGaD
Betamethasone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000261	0.00797	CbGpPWpGaD
Betamethasone—CYP19A1—central nervous system—amyotrophic lateral sclerosis	0.000257	0.0165	CbGeAlD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000256	0.00783	CbGpPWpGaD
Betamethasone—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000246	0.00366	CcSEcCtD
Betamethasone—NR3C2—brain—amyotrophic lateral sclerosis	0.000244	0.0157	CbGeAlD
Betamethasone—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000242	0.00361	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000241	0.00737	CbGpPWpGaD
Betamethasone—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000234	0.00349	CcSEcCtD
Betamethasone—NR3C1—medulla oblongata—amyotrophic lateral sclerosis	0.000228	0.0147	CbGeAlD
Betamethasone—PGR—brain—amyotrophic lateral sclerosis	0.000227	0.0146	CbGeAlD
Betamethasone—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000227	0.00338	CcSEcCtD
Betamethasone—PGR—Validated nuclear estrogen receptor alpha network—SOD1—amyotrophic lateral sclerosis	0.00022	0.00674	CbGpPWpGaD
Betamethasone—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000218	0.00325	CcSEcCtD
Betamethasone—Rash—Riluzole—amyotrophic lateral sclerosis	0.000216	0.00322	CcSEcCtD
Betamethasone—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000216	0.00322	CcSEcCtD
Betamethasone—Headache—Riluzole—amyotrophic lateral sclerosis	0.000215	0.0032	CcSEcCtD
Betamethasone—NR3C2—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000208	0.00637	CbGpPWpGaD
Betamethasone—CYP19A1—brain—amyotrophic lateral sclerosis	0.000204	0.0131	CbGeAlD
Betamethasone—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000204	0.00303	CcSEcCtD
Betamethasone—NR3C1—spinal cord—amyotrophic lateral sclerosis	0.000203	0.0131	CbGeAlD
Betamethasone—PGR—Signaling by ERBB4—GFAP—amyotrophic lateral sclerosis	0.000203	0.0062	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.0002	0.00611	CbGpPWpGaD
Betamethasone—PTGS2—medulla oblongata—amyotrophic lateral sclerosis	0.000197	0.0127	CbGeAlD
Betamethasone—PLA2G1B—Phospholipid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000192	0.00587	CbGpPWpGaD
Betamethasone—ABCB1—embryo—amyotrophic lateral sclerosis	0.000191	0.0123	CbGeAlD
Betamethasone—PTGS2—Signaling mediated by p38-alpha and p38-beta—ATF1—amyotrophic lateral sclerosis	0.000183	0.0056	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000177	0.00542	CbGpPWpGaD
Betamethasone—PTGS2—spinal cord—amyotrophic lateral sclerosis	0.000176	0.0113	CbGeAlD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.000176	0.00538	CbGpPWpGaD
Betamethasone—PGR—Validated nuclear estrogen receptor alpha network—C3—amyotrophic lateral sclerosis	0.000175	0.00534	CbGpPWpGaD
Betamethasone—NR3C2—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000172	0.00527	CbGpPWpGaD
Betamethasone—NR3C1—nervous system—amyotrophic lateral sclerosis	0.000171	0.011	CbGeAlD
Betamethasone—NR3C1—Adipogenesis—RARA—amyotrophic lateral sclerosis	0.000166	0.00508	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.000165	0.00506	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000165	0.00505	CbGpPWpGaD
Betamethasone—NR3C1—central nervous system—amyotrophic lateral sclerosis	0.000165	0.0106	CbGeAlD
Betamethasone—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—amyotrophic lateral sclerosis	0.000163	0.00499	CbGpPWpGaD
Betamethasone—NR3C1—cerebellum—amyotrophic lateral sclerosis	0.000161	0.0104	CbGeAlD
Betamethasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000161	0.00491	CbGpPWpGaD
Betamethasone—PTGS2—Prostaglandin Synthesis and Regulation—PLA2G4A—amyotrophic lateral sclerosis	0.000159	0.00485	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000158	0.00483	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.000152	0.00466	CbGpPWpGaD
Betamethasone—PTGS2—nervous system—amyotrophic lateral sclerosis	0.000148	0.00954	CbGeAlD
Betamethasone—CYP19A1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000143	0.00437	CbGpPWpGaD
Betamethasone—PTGS2—central nervous system—amyotrophic lateral sclerosis	0.000143	0.00918	CbGeAlD
Betamethasone—PTGS2—Signaling mediated by p38-alpha and p38-beta—PLA2G4A—amyotrophic lateral sclerosis	0.00014	0.00429	CbGpPWpGaD
Betamethasone—PTGS2—cerebellum—amyotrophic lateral sclerosis	0.00014	0.00898	CbGeAlD
Betamethasone—PLA2G1B—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000134	0.0041	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000134	0.0041	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—RTN4—amyotrophic lateral sclerosis	0.000133	0.00408	CbGpPWpGaD
Betamethasone—NR3C1—brain—amyotrophic lateral sclerosis	0.000131	0.00842	CbGeAlD
Betamethasone—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00013	0.00834	CbGeAlD
Betamethasone—PGR—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000127	0.00388	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000125	0.00383	CbGpPWpGaD
Betamethasone—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000125	0.00802	CbGeAlD
Betamethasone—PGR—Signaling by ERBB4—CASP9—amyotrophic lateral sclerosis	0.000123	0.00376	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000123	0.00375	CbGpPWpGaD
Betamethasone—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000122	0.00785	CbGeAlD
Betamethasone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—amyotrophic lateral sclerosis	0.000117	0.00356	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.000115	0.00353	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000114	0.00349	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000113	0.00347	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.000113	0.00347	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.000113	0.00347	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.000113	0.00347	CbGpPWpGaD
Betamethasone—PTGS2—brain—amyotrophic lateral sclerosis	0.000113	0.00729	CbGeAlD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00011	0.00336	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000109	0.00335	CbGpPWpGaD
Betamethasone—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000109	0.007	CbGeAlD
Betamethasone—PTGS2—Spinal Cord Injury—GFAP—amyotrophic lateral sclerosis	0.000109	0.00332	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000108	0.0033	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—AQP4—amyotrophic lateral sclerosis	0.000107	0.00329	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000107	0.00328	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—amyotrophic lateral sclerosis	0.000105	0.00323	CbGpPWpGaD
Betamethasone—PTGS2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000105	0.00323	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—ERBB4—amyotrophic lateral sclerosis	0.000105	0.00322	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000105	0.00321	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000102	0.00311	CbGpPWpGaD
Betamethasone—PTGS2—S1P1 pathway—VEGFA—amyotrophic lateral sclerosis	0.000102	0.00311	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000101	0.00308	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	9.85e-05	0.00301	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—DAO—amyotrophic lateral sclerosis	9.7e-05	0.00297	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—ZNF746—amyotrophic lateral sclerosis	9.61e-05	0.00294	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	9.35e-05	0.00286	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	9.25e-05	0.00283	CbGpPWpGaD
Betamethasone—Triamcinolone—PTGS2—amyotrophic lateral sclerosis	9.17e-05	0.0831	CrCbGaD
Betamethasone—ABCB1—nervous system—amyotrophic lateral sclerosis	9.17e-05	0.0059	CbGeAlD
Betamethasone—ABCB1—central nervous system—amyotrophic lateral sclerosis	8.83e-05	0.00568	CbGeAlD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	8.79e-05	0.00269	CbGpPWpGaD
Betamethasone—ABCB1—cerebellum—amyotrophic lateral sclerosis	8.63e-05	0.00555	CbGeAlD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—ATF1—amyotrophic lateral sclerosis	8.51e-05	0.0026	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—RARA—amyotrophic lateral sclerosis	8.29e-05	0.00254	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—CASP9—amyotrophic lateral sclerosis	8.1e-05	0.00248	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	8.04e-05	0.00246	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	7.48e-05	0.00229	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PLB1—amyotrophic lateral sclerosis	7.35e-05	0.00225	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	7.35e-05	0.00225	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—ZNF470—amyotrophic lateral sclerosis	7.33e-05	0.00224	CbGpPWpGaD
Betamethasone—ABCB1—brain—amyotrophic lateral sclerosis	7.01e-05	0.00451	CbGeAlD
Betamethasone—PLA2G1B—Metabolism—GSR—amyotrophic lateral sclerosis	6.78e-05	0.00207	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	6.72e-05	0.00206	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	6.66e-05	0.00204	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	6.55e-05	0.002	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	6.44e-05	0.00197	CbGpPWpGaD
Betamethasone—CYP19A1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	6.39e-05	0.00196	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	6.36e-05	0.00194	CbGpPWpGaD
Betamethasone—CYP19A1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	6.3e-05	0.00193	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	6.25e-05	0.00191	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—SMN1—amyotrophic lateral sclerosis	6.23e-05	0.00191	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—FUS—amyotrophic lateral sclerosis	6.19e-05	0.00189	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	6.18e-05	0.00189	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	6.17e-05	0.00189	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	6.06e-05	0.00185	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	6.03e-05	0.00184	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	6e-05	0.00183	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	5.88e-05	0.0018	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	5.87e-05	0.00179	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	5.81e-05	0.00178	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—CHAT—amyotrophic lateral sclerosis	5.57e-05	0.0017	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—BDNF—amyotrophic lateral sclerosis	5.56e-05	0.0017	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—ZNF746—amyotrophic lateral sclerosis	5.55e-05	0.0017	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—amyotrophic lateral sclerosis	5.52e-05	0.00169	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—MMP9—amyotrophic lateral sclerosis	5.26e-05	0.00161	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	5.18e-05	0.00159	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	5.08e-05	0.00155	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—RARA—amyotrophic lateral sclerosis	5.05e-05	0.00154	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	5.01e-05	0.00153	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—VAPB—amyotrophic lateral sclerosis	4.9e-05	0.0015	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—TPK1—amyotrophic lateral sclerosis	4.9e-05	0.0015	CbGpPWpGaD
Betamethasone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—amyotrophic lateral sclerosis	4.71e-05	0.00144	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	4.58e-05	0.0014	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.57e-05	0.0014	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	4.51e-05	0.00138	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	4.49e-05	0.00137	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—VAPA—amyotrophic lateral sclerosis	4.48e-05	0.00137	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—IGF1—amyotrophic lateral sclerosis	4.41e-05	0.00135	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	4.37e-05	0.00134	CbGpPWpGaD
Betamethasone—Dexamethasone—PTGS2—amyotrophic lateral sclerosis	4.37e-05	0.0396	CrCbGaD
Betamethasone—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	4.17e-05	0.00128	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.17e-05	0.00127	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	4.12e-05	0.00126	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	4.03e-05	0.00123	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—FIG4—amyotrophic lateral sclerosis	3.92e-05	0.0012	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TPK1—amyotrophic lateral sclerosis	3.91e-05	0.0012	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	3.85e-05	0.00118	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	3.78e-05	0.00116	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	3.75e-05	0.00115	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	3.61e-05	0.0011	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—FUS—amyotrophic lateral sclerosis	3.58e-05	0.00109	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—TP53—amyotrophic lateral sclerosis	3.57e-05	0.00109	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—DAO—amyotrophic lateral sclerosis	3.54e-05	0.00108	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.48e-05	0.00107	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	3.47e-05	0.00106	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	3.42e-05	0.00105	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	3.41e-05	0.00104	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—TPK1—amyotrophic lateral sclerosis	3.27e-05	0.001	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—VAPB—amyotrophic lateral sclerosis	3.27e-05	0.001	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	3.22e-05	0.000985	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	3.18e-05	0.000973	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—amyotrophic lateral sclerosis	3.14e-05	0.000962	CbGpPWpGaD
Betamethasone—PTGS2—Disease—VTA1—amyotrophic lateral sclerosis	3.12e-05	0.000956	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.05e-05	0.000934	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—VCP—amyotrophic lateral sclerosis	3.05e-05	0.000933	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.99e-05	0.000916	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—VAPA—amyotrophic lateral sclerosis	2.99e-05	0.000916	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.95e-05	0.000904	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	2.93e-05	0.000896	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—RARA—amyotrophic lateral sclerosis	2.92e-05	0.000893	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	2.9e-05	0.000886	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.78e-05	0.000851	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	2.78e-05	0.000849	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.75e-05	0.000842	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	2.71e-05	0.00083	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.68e-05	0.000821	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	2.68e-05	0.00082	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	2.66e-05	0.000813	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	2.62e-05	0.000803	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	2.62e-05	0.000803	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—FIG4—amyotrophic lateral sclerosis	2.62e-05	0.0008	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	2.59e-05	0.000794	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	2.56e-05	0.000783	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	2.49e-05	0.000761	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GSR—amyotrophic lateral sclerosis	2.48e-05	0.000758	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	2.45e-05	0.000751	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	2.42e-05	0.00074	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CHMP2B—amyotrophic lateral sclerosis	2.37e-05	0.000724	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—DAO—amyotrophic lateral sclerosis	2.37e-05	0.000724	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.32e-05	0.00071	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.32e-05	0.00071	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	2.3e-05	0.000704	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—APOE—amyotrophic lateral sclerosis	2.26e-05	0.000692	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.26e-05	0.00069	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	2.19e-05	0.000669	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PLB1—amyotrophic lateral sclerosis	2.14e-05	0.000655	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.12e-05	0.000649	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.06e-05	0.000629	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.06e-05	0.000629	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.03e-05	0.000622	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.97e-05	0.000603	CbGpPWpGaD
Betamethasone—PTGS2—Disease—VCP—amyotrophic lateral sclerosis	1.91e-05	0.000584	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.89e-05	0.000578	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.87e-05	0.000571	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.86e-05	0.000568	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.85e-05	0.000567	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.84e-05	0.000563	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	1.83e-05	0.000561	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.79e-05	0.000549	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.78e-05	0.000545	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	1.78e-05	0.000545	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	1.74e-05	0.000532	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	1.68e-05	0.000513	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.67e-05	0.000511	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GSR—amyotrophic lateral sclerosis	1.66e-05	0.000506	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.6e-05	0.00049	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.59e-05	0.000487	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.55e-05	0.000474	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.51e-05	0.000461	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	1.44e-05	0.000441	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1.43e-05	0.000437	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1.43e-05	0.000437	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CST3—amyotrophic lateral sclerosis	1.37e-05	0.000419	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.36e-05	0.000417	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.36e-05	0.000416	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.34e-05	0.00041	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	1.31e-05	0.0004	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.28e-05	0.000392	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.27e-05	0.000389	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.27e-05	0.000389	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.24e-05	0.000379	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.22e-05	0.000372	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.21e-05	0.00037	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	1.17e-05	0.000359	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.14e-05	0.00035	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.14e-05	0.000348	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.13e-05	0.000346	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.09e-05	0.000334	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.05e-05	0.000322	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	1.03e-05	0.000316	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1e-05	0.000307	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CASP9—amyotrophic lateral sclerosis	9.96e-06	0.000305	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	9.63e-06	0.000295	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.71e-06	0.000266	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	8.59e-06	0.000263	CbGpPWpGaD
Betamethasone—PTGS2—Disease—ERBB4—amyotrophic lateral sclerosis	8.53e-06	0.000261	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—APOE—amyotrophic lateral sclerosis	8.27e-06	0.000253	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	7.83e-06	0.00024	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.3e-06	0.000223	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	7.23e-06	0.000221	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.71e-06	0.000205	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.71e-06	0.000205	CbGpPWpGaD
Betamethasone—PTGS2—Disease—APOE—amyotrophic lateral sclerosis	6.59e-06	0.000202	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.34e-06	0.000194	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	5.94e-06	0.000182	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.69e-06	0.000174	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.66e-06	0.000173	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—APOE—amyotrophic lateral sclerosis	5.52e-06	0.000169	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.18e-06	0.000158	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.76e-06	0.000146	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.3e-06	0.000132	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	3.92e-06	0.00012	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.19e-06	9.76e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.93e-06	8.97e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.68e-06	8.21e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.41e-06	7.38e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.65e-06	5.06e-05	CbGpPWpGaD
